These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 9690730)

  • 61. Omeprazole-based dual and triple regimens for Helicobacter pylori eradication in children.
    Kato S; Takeyama J; Ebina K; Naganuma H
    Pediatrics; 1997 Jul; 100(1):E3. PubMed ID: 9200377
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Concomitant, sequential, and hybrid therapy for H. pylori eradication: a pilot study.
    Zullo A; Scaccianoce G; De Francesco V; Ruggiero V; D'Ambrosio P; Castorani L; Bonfrate L; Vannella L; Hassan C; Portincasa P
    Clin Res Hepatol Gastroenterol; 2013 Dec; 37(6):647-50. PubMed ID: 23747131
    [TBL] [Abstract][Full Text] [Related]  

  • 63. 4-day triple therapy with rabeprazole, amoxicillin and clarithromycin in the eradication of Helicobacter pylori in patients with peptic ulcer disease--A pilot study.
    Lüth S; Teyssen S; Kölbel CB; Singer MV
    Z Gastroenterol; 2001 Apr; 39(4):279-81, 284-5. PubMed ID: 11367976
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison of the efficacy of 1-day high-dose quadruple therapy versus 7-day triple therapy for treatment of Helicobacter pylori infection.
    Zheng Q; Pan Y; Zhang L; Xiao SD
    Chin J Dig Dis; 2005; 6(4):202-5. PubMed ID: 16246231
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Dual versus triple therapy: comparison of five antibiotic regimens for eradication of Helicobacter pylori in a prospective, randomized study.
    Kirstein FW; Epple HJ; Bojarski C; Victor L; Fromm M; Riecken EO; Schulzke JD
    Z Gastroenterol; 1998 Sep; 36(9):803-9. PubMed ID: 9795409
    [TBL] [Abstract][Full Text] [Related]  

  • 66. One-week use of ranitidine bismuth citrate, amoxycillin and clarithromycin for the treatment of Helicobacter pylori-related duodenal ulcer.
    Sung JJ; Leung WK; Ling TK; Yung MY; Chan FK; Lee YT; Cheng AF; Chung SC
    Aliment Pharmacol Ther; 1998 Aug; 12(8):725-30. PubMed ID: 9726384
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Randomized comparison of differing periods of twice-a-day triple therapy for the eradication of Helicobacter pylori.
    Laine L; Estrada R; Trujillo M; Fukanaga K; Neil G
    Aliment Pharmacol Ther; 1996 Dec; 10(6):1029-33. PubMed ID: 8971306
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: results of a multicentre study in South-East Asia. South-East Asia Multicenter Study Group.
    Fock KM; Chelvam P; Lim SG
    Aliment Pharmacol Ther; 2000 Feb; 14(2):225-31. PubMed ID: 10651664
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy.
    Zanten SJ; Bradette M; Farley A; Leddin D; Lind T; Unge P; Bayerdörffer E; Spiller RC; O'Morain C; Sipponen P; Wrangstadh M; Zeijlon L; Sinclair P
    Aliment Pharmacol Ther; 1999 Mar; 13(3):289-95. PubMed ID: 10102960
    [TBL] [Abstract][Full Text] [Related]  

  • 70. One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer.
    Tzivras M; Archimandritis A; Balatsos V; Delis V; Souyioultzis S; Skandalis N; Kanellopoulou E; Manika Z; Davaris P
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1185-9. PubMed ID: 9471024
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pantoprazole-based dual and triple therapy for the eradication of Helicobacter pylori infection: a randomized controlled trial.
    Svoboda P; Kantorová I; Ochmann J; Doubek J; Kozumplík L; Marsová J
    Hepatogastroenterology; 1997; 44(15):886-90. PubMed ID: 9222709
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of the efficacy and tolerability of four different therapeutic regimens for the Helicobacter pylori eradication.
    Tursi A; Cammarota G; Montalto M; Papa A; Cuoco L; Veneto GM; Cannizzaro O; Fedeli G; Gasbarrini G
    Panminerva Med; 1996 Sep; 38(3):145-9. PubMed ID: 9009677
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER Study.
    Zagari RM; Bianchi-Porro G; Fiocca R; Gasbarrini G; Roda E; Bazzoli F
    Gut; 2007 Apr; 56(4):475-9. PubMed ID: 17028126
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial.
    Ramas M; Donday MG; McNicholl AG; Gisbert JP
    Gastroenterol Hepatol; 2017 Dec; 40(10):658-662. PubMed ID: 28780968
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CagA status and Helicobacter pylori eradication among dyspeptic patients.
    Magalhães AF; Carvalhaes A; Natan-Eisig J; Paraíso-Ferraz JG; Trevisan M; Zaterkaad S
    Gastroenterol Hepatol; 2005 Oct; 28(8):441-4. PubMed ID: 16185577
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Omeprazole-based antimicrobial therapies: results in 198 Helicobacter pylori-positive patients.
    Deltenre M; Jonas C; van Gossum M; Buset M; Otero J; De Koster E
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S39-44. PubMed ID: 8574734
    [TBL] [Abstract][Full Text] [Related]  

  • 77. High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study.
    Peitz U; Sulliga M; Wolle K; Leodolter A; Von Arnim U; Kahl S; Stolte M; Börsch G; Labenz J; Malfertheiner P
    Aliment Pharmacol Ther; 2002 Feb; 16(2):315-24. PubMed ID: 11860415
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Duodenal ulcer healing with 1-week eradication triple therapy followed, or not, by anti-secretory treatment: a multicentre double-blind placebo-controlled trial.
    Colin R;
    Aliment Pharmacol Ther; 2002 Jun; 16(6):1157-62. PubMed ID: 12030959
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.
    Uygun A; Kadayifci A; Yesilova Z; Safali M; Ilgan S; Karaeren N
    Clin Ther; 2008 Mar; 30(3):528-34. PubMed ID: 18405790
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection: comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole.
    Miwa H; Yamada T; Sato K; Ohta K; Ohkura R; Murai T; Nagahara A; Takei Y; Ogihara T; Sato N
    Dig Dis Sci; 2000 Jan; 45(1):77-82. PubMed ID: 10695617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.